Switzerland· 54670003
Zavedos Solution 20 mg, Konzentrat zur Herstellung einer Infusionslösung
A idarubicin product, registered in Switzerland by Pfizer AG and dispensed under Swissmedic category A. The same ATC class is registered in 17 of our 19 countries.
Checked against the register on
Informational only — not a medical device.
Where it is registered
Idarubicin is registered in 17 of 19 countries.
Countries holding a registration under ATC L01DB06 (idarubicin), each read from that country’s own register.
- This record: Switzerland
- 10 of them publish a price we can compare per daily dose
Idarubicin · ATC L01DB06
17 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
- Manufacturer
- Pfizer AG
- Country
- Switzerland (CH)
- ATC code
- L01DB06
- ATC class
- Idarubicin
- Defined daily dose
- 6 mg, O
- Swissmedic category
- A
- Reimbursed
- No
- Last checked
- June 26, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
435 interactions on record for idarubicin.
Graded by severity as the source publishes them — 98 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Idarubicin · interactions on record
435 records
- 98 severe
- 328 moderate
- 9 minor
Most severe, free to view
- PapaverineA03AD01severe
- CisaprideA03FA02severe
- DolasetronA04AA04severe
- QuinidineC01BA01severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under L01DB06
Idarubicin, as other registers publish it.
- United StatesIdamycin PFSPfizer Laboratories Div Pfizer Inc
- United StatesIdamycin PFSPfizer Laboratories Div Pfizer Inc
- United StatesIdamycin PFSPfizer Laboratories Div Pfizer Inc
- CanadaIDARUBICINPFIZER CANADA ULC
- United KingdomIdarubicin 10mg powder for solution for injection vialsTeva UK Ltd
- United KingdomIdarubicin 10mg/10ml solution for injection vialsA A H Pharmaceuticals Ltd
- United KingdomIdarubicin 10mg/10ml solution for injection vialsTeva UK Ltd
- United KingdomIdarubicin 10mg/10ml solution for injection vialsAccord-UK Ltd
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of the issuing authority. This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c004a6da-9bf3-4b7c-9187-67108bd38602 GET /v1/drugs/c004a6da-9bf3-4b7c-9187-67108bd38602?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "swissmedic_auth",
"heilmittelcode": "Synthetika"
}See everything about idarubicin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.